CV Sciences, Inc.
CVSI
$0.03
$0.009.68%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.98M | 15.31M | 15.71M | 15.62M | 15.85M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.98M | 15.31M | 15.71M | 15.62M | 15.85M |
| Cost of Revenue | 8.02M | 8.34M | 8.54M | 8.39M | 8.55M |
| Gross Profit | 6.96M | 6.97M | 7.17M | 7.23M | 7.30M |
| SG&A Expenses | 8.13M | 8.16M | 8.45M | 8.74M | 8.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -522.00K | -522.00K | -- | 0.00 | 0.00 |
| Total Operating Expenses | 15.76M | 16.08M | 17.11M | 17.26M | 17.66M |
| Operating Income | -784.00K | -772.00K | -1.40M | -1.64M | -1.81M |
| Income Before Tax | -1.56M | -1.88M | -2.40M | -2.54M | -2.53M |
| Income Tax Expenses | -7.00K | -7.00K | -8.00K | -3.00K | -3.00K |
| Earnings from Continuing Operations | -1.55 | -1.88 | -2.39 | -2.54 | -2.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.55M | -1.88M | -2.39M | -2.54M | -2.53M |
| EBIT | -784.00K | -772.00K | -1.40M | -1.64M | -1.81M |
| EBITDA | -449.00K | -419.00K | -1.07M | -1.36M | -1.56M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 735.12M | 723.27M | 702.08M | 674.23M | 646.58M |
| Average Diluted Shares Outstanding | 735.12M | 723.27M | 702.08M | 674.23M | 646.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |